Charles River Laboratories International, Inc. ( CRL) - Stock Earnings
CRL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 54.4 million USD | 1.0 billion USD |
| 2025Q4 | -276.6 million USD | 994.2 million USD |
| 2026Q1 | -14.8 million USD | 995.8 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CRL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 474.6 million USD | 4.1 billion USD |
| 2024 | 10.3 million USD | 4.0 billion USD |
| 2025 | -144.3 million USD | 4.0 billion USD |
| 2026 Est. | — | — |
CRL
Price: $181.34
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.71 USD
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 411300
Ebitda: 110.3 millionMarket Capitalization: 8.9 billion